Patterns of alternation in irritable bowel syndrome
- PMID: 27152072
- PMCID: PMC4849379
- DOI: 10.15386/cjmed-589
Patterns of alternation in irritable bowel syndrome
Abstract
Background and aims: Irritable bowel syndrome (IBS) is one of the most frequent functional gastrointestinal disorders, having its subtypes related to the predominant bowel pattern: IBS with diarrhea (IBS-D), IBS with constipation (IBS-C), mixed IBS (IBS-M) or alternating IBS (IBS-A). Some patients alternate between subtypes (IBS-A). We looked for the prevalence of alternation between subtypes in patients with IBS. We also analyzed changes in pharmacological therapy specifically addressed to IBS.
Methods: We performed a retrospective observational study that included 60 patients diagnosed with IBS according to Rome III criteria. Patients were asked using a detailed structured interview about their stool form changes regarding previous six months. Alternators were defined as patients that changed IBS subtype over time (previous six months).
Results: Out of the 60 patients diagnosed with IBS, 18 patients (30%) were alternators. Of these, 8 patients (44%) changed twice the subtype. Two patients (66.66%) of the IBS-M subgroup shifted between subtypes. Eight patients (44.44%) changed medication over the six months. Four patients (22.2%) of the alternators were on double association of therapy (antispasmodics) addressed to IBS. Four patients (22.22%) discontinued medication.
Conclusions: Patients with IBS often change between subtypes even within six months. Alternators in our pilot study represented 30% of IBS patients. IBS-M seems to be the least stable phenotype. The rarest change is the shift between IBS-C and IBS-D. Alternators also often change their pharmacological treatment (antispasmodics).
Keywords: alternators; constipation; diarrhea; gastrointestinal diseases; irritable bowel syndrome; therapy.
Figures
Similar articles
-
Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.J Gastroenterol Hepatol. 2012 Apr;27(4):760-5. doi: 10.1111/j.1440-1746.2011.06930.x. J Gastroenterol Hepatol. 2012. PMID: 21929652
-
Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype.Eur J Gastroenterol Hepatol. 2003 Feb;15(2):165-72. doi: 10.1097/00042737-200302000-00010. Eur J Gastroenterol Hepatol. 2003. PMID: 12560761
-
A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator.Gastroenterology. 2005 Mar;128(3):580-9. doi: 10.1053/j.gastro.2004.12.006. Gastroenterology. 2005. PMID: 15765393
-
Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea.Front Pharmacol. 2021 Feb 18;11:629026. doi: 10.3389/fphar.2020.629026. eCollection 2020. Front Pharmacol. 2021. PMID: 33679391 Free PMC article. Review.
-
Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline.Pharmacotherapy. 2016 Mar;36(3):300-16. doi: 10.1002/phar.1712. Epub 2016 Mar 11. Pharmacotherapy. 2016. PMID: 26971716 Review.
Cited by
-
Assessment of Urinary Dopamine and Serotonin Metabolites in Relation to Dysbiosis Indicators in Patients with Functional Constipation.Nutrients. 2024 Sep 4;16(17):2981. doi: 10.3390/nu16172981. Nutrients. 2024. PMID: 39275296 Free PMC article.
-
The Variability of Tryptophan Metabolism in Patients with Mixed Type of Irritable Bowel Syndrome.Int J Mol Sci. 2024 Feb 22;25(5):2550. doi: 10.3390/ijms25052550. Int J Mol Sci. 2024. PMID: 38473797 Free PMC article.
-
Low-FODMAP diet on postprandial distress syndrome type of functional dyspepsia with mixed type of irritable bowel syndrome patient: A case report.Narra J. 2024 Aug;4(2):e759. doi: 10.52225/narra.v4i2.759. Epub 2024 May 24. Narra J. 2024. PMID: 39280305 Free PMC article.
-
Periodic Changes in the Gut Microbiome in Women with the Mixed Type of Irritable Bowel Syndrome.Biomedicines. 2025 Mar 7;13(3):652. doi: 10.3390/biomedicines13030652. Biomedicines. 2025. PMID: 40149628 Free PMC article.
-
Healthcare Utilization Patterns: Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Gastroesophageal Reflux Disease.Dig Dis Sci. 2024 May;69(5):1626-1635. doi: 10.1007/s10620-024-08297-w. Epub 2024 Feb 24. Dig Dis Sci. 2024. PMID: 38400884 Free PMC article.
References
-
- Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480–1491. - PubMed
-
- Choung RS, Locke GR., 3rd Epidemiology of IBS. Gastroenterol Clin North Am. 2011;40(1):1–10. - PubMed
-
- Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123:2108–2131. - PubMed
-
- Quigley EM, Abdel-Hamid H, Barbara G, Bhatia SJ, Boeckxstaens G, De Giorgio R, et al. A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. J Clin Gastroenterol. 2012;46:356–366. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources